Bharat Biotech asked to submit complete ph 2 data of its COVID-19 vaccine before ph 3 trial | India News,The Indian Express

Bharat Biotech asked to submit complete ph 2 data of its COVID-19 vaccine before ph 3 trial | India News,The Indian Express

Bharat Biotech asked to submit complete ph 2 data of its COVID-19 vaccine before ph 3 trial

By: PTI | New Delhi | Updated: October 10, 2020 at 5:10 pm

The company has applied to the Drugs Controller General of India (DCGI) on October 2, seeking its permission to conduct phase-3 randomised double-blind placebo-controlled multicentre trial of its COVID-19 vaccine candidate.